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Edited by Irmgard SinningAbstract ISG20 is an interferon-induced antiviral exoribonuc-
lease that acts on single-stranded RNA and also has minor
activity towards single-stranded DNA. It belongs to the DEDDh
group of RNases of the DEDD exonuclease superfamily. We
have solved the crystal structure of human ISG20 complexed
with two Mn2þ ions and uridine 50-monophosphate (UMP) at 1.9
A resolution. Its structure, including that of the active site, is
very similar to those of the corresponding domains of two
DEDDh-group DNases, the e subunit of Escherichia coli DNA
polymerase III and E. coli exonuclease I, strongly suggesting
that its catalytic mechanism is identical to that of the two
DNases. However, ISG20 also has distinctive residues, Met14
and Arg53, to accommodate hydrogen bonds with the 20-OH
group of the UMP ribose, and these residues may be responsible
for the preference of ISG20 for RNA substrates.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Interferons comprise a family of secretory proteins charac-
terized chieﬂy by their ability to induce cellular antiviral pro-
teins. Among the well-studied interferon-induced antiviral
proteins are the double-stranded RNA-dependent protein ki-
nase PKR, the 20,50-oligoadenylate synthetase/RNase L sys-
tem, and the Mx family of GTPases [1–4].
ISG20 (interferon-stimulated gene product of 20 kDa) is a
protein induced by interferons or double-stranded RNA [5,6].
Its involvement in antiviral mechanisms was elucidated in a
recent study [7], where it was demonstrated that overexpres-
sion of recombinant ISG20 in cultured cells increases cellular
resistance to infection by some RNA genomic viruses. More-
over, mouse embryonic ﬁbroblasts triply deﬁcient in PKR,
RNase L and Mx gene expression still exhibit residual antiviral
activity, the extent of which is correlated with the amount of
interferon-induced expression of endogenous ISG20 protein
[7]. These facts suggest that ISG20 may participate in an al-
ternative interferon-mediated antiviral pathway.* Corresponding author. Fax: +81-29-850-6217.
E-mail address: t.horio@nippon-shinyaku.co.jp (T. Horio).
Abbreviations: UMP, uridine 50-monophosphate
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doi:10.1016/j.febslet.2004.09.074ISG20 is a 30 to 50 exonuclease with a strong preference for
single-stranded RNA substrates and minor activity towards
single-stranded DNA [8]. According to sequence-alignment
analyses, ISG20 belongs to the DEDD superfamily, a 30 to 50
exonuclease superfamily deﬁned by four conserved acidic res-
idues, three aspartates (D) and one glutamate (E), distributed
among three separate sequence motifs (ExoI–III) [9,10]. Ex-
onucleases in this superfamily require two divalent metal ions
for catalytic activity, and the four conserved residues play a
crucial role in binding the metal ions at the active site. The
DEDD superfamily can be subdivided into two groups,
DEDDy and DEDDh, which are distinguished according to
whether a ﬁfth conserved residue is tyrosine (y) or histidine (h).
These Tyr and His residues are also located at the active site
and are presumed to play an equivalent role in activating the
water molecule which is destined to attack the phosphorus
atom in the target phosphodiester bond. While the DEDD
superfamily includes both DNases and RNases, their substrate
speciﬁcity is not correlated with their assignment to the
DEDDy or the DEDDh group. For example, ISG20 and some
other RNases such as RNase T and oligoribonuclease are in-
cluded in the DEDDh group along with some DNases such as
the proofreading domain of bacterial DNA polymerase III,
while RNase D and the proofreading domains of A or B type
DNA polymerases are included in the DEDDy group. Most
current knowledge of the structure and catalytic mechanism of
DEDD exonucleases is derived from studies of DNases [12–22]
(Table 1); RNases in this superfamily have been far less well
studied from a structural point of view, although the crystal
structure of the RNase domain of Saccharomyces cerevisiae
Pop2, a DEDD-superfamily-related protein with non-canoni-
cal active-site residues, has recently been reported [11].
We here report the crystal structure of human ISG20, a
DEDDh-group RNase, complexed with two manganese ions
and uridine 50-monophosphate (UMP), a product of the
exonuclease reaction, at 1.9 A resolution. The structure of
ISG20, especially around the active site, is similar to those
of the corresponding domains of two DEDDh-group DNa-
ses (members of the DnaQ superfamily), the e subunit of
Escherichia coli DNA polymerase III [12] and E. coli exo-
nuclease I [13], strongly suggesting that these three enzymes
have a common catalytic mechanism. However, ISG20 rec-
ognizes the sugar moiety of the nucleotide in a slightly
diﬀerent manner from the two DNases, to accommodate
hydrogen bonds with the ribose 20-OH group of UMP. Thisblished by Elsevier B.V. All rights reserved.
Table 1
Crystal-structural studies of DEDDh-group DNases
Resolution (A) Ligand(s) PDB code Reference
E. coli DNA polymerase III
e subunit N-terminal domain (e186)
1.8/1.7a
(pH 8.5/pH 5.8)
Two Mn2þ ions
and dTMP
1J53/1J54a [12]
E. coli exonuclease I (ExoI) 2.4 One Mg2þ ion 1FXX [13]
a The structure was solved at diﬀerent pH values.
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RNA substrates.2. Materials and methods
2.1. Puriﬁcation and crystallization
The gene coding for human ISG20 was cloned into the expression
vector pET28a (Novagen, Madison, WI, USA) as described elsewhere
[8]. The ISG20 protein, tagged with six histidine residues at the C-
terminus, was expressed in the E. coli strain BL21 (DE3) (Novagen)
and puriﬁed on a nickel-chelating aﬃnity column (HisBind Fractogel;
Novagen) and a cation-exchange column (HiTrap SP HP; Amersham
Biosciences, Piscataway, NJ, USA). The puriﬁed protein was concen-
trated to 15 mg/ml in 0.1 M sodium acetate, pH 5.5, containing 0.3 M
NaCl with Centriprep and Centricon centrifugal ﬁlter units (Millipore,
Billerica, MA, USA). Protein solution (0.5 ll) was mixed with an equal
volume of crystallization solution (0.2 M sodium acetate, pH 5.5,
containing 2.6–2.9 M NaCl and 0.8% (v/v) 1-butanol) and equilibrated
against the crystallization solution for about 1 h by the hanging drop
vapor diﬀusion method, after which crystallization was initiated by
microseeding. After 3–4 days at 23 C, hexagonal needle-shaped
crystals 0.5–1.0 mm in length and 0.05 mm in width were obtained.
2.2. Diﬀraction measurement and data processing
All diﬀraction data were collected at the BL32B2 beamline of the
SPring-8 synchrotron radiation facility (Hyogo, Japan) with a Rigaku
R-AXIS V imaging plate detector. For data collection at 100 K, a
crystal was transferred to cryoprotectant (crystallization solution
containing 30% glycerol) and, after twenty to thirty seconds, ﬂash-
cooled in a liquid-nitrogen gas stream. Diﬀraction data were processed
with the HKL2000 package [23]. The ISG20 crystal had unit-cell di-
mensions of a ¼ b ¼ 63:1 A and c ¼ 97:8 A in space group P3221, with
one molecule per asymmetric unit. The calculated solvent content of
the crystal was 53%.
2.3. MAD data collection and MAD phasing
To determine the structure by the multiple-wavelength anomalous-
dispersion (MAD) method, the Hg derivative was prepared by soaking
a crystal in crystallization solution containing 10 mM mercury (II)
acetate for about 35 h. From this crystal, the same 60 wedge of data
was collected at each of the three wavelengths (edge¼ 1.0085 A,Table 2
Data collection and MAD phasing statistics
Hg(II) acetate
Edge Peak
Wavelength (A) 1.0085 1.0050
Cell dimensions a, c (A) 63.1, 97.8 63.1, 97.8
Resolution range (A) 50–2.5 (2.59–2.5) 50–2.5 (2.59–2.5)
No. of observed reﬂections 28 074 28 167
No. of unique reﬂections 8188 8175
Completeness (%) 99.9 (99.9) 99.9 (100)
I/r(I) 13.5 (8.4) 13.5 (8.4)
Rsym (%)a 6.2 (12.1) 6.6 (12.8)
Phasing power, iso/ano 0.98/2.13 0.72/2.14
Figure of merit – –
Values in parentheses refer to the highest-resolution shell.
aRsym ¼ ð
P jI  hIijÞ=ðP IÞ, where I is the observed intensity and ÆIæ is thepeak¼ 1.0050 A, and remote¼ 0.92 A) (Table 2). Heavy-atom search
and phase calculations were carried out with the CNX package (Ac-
celrys Inc., San Diego, CA, USA). From the correspondence of the
signiﬁcant peaks of the dispersive and anomalous diﬀerence Patterson
maps, it could be determined that there was one Hg atom site per
ISG20 molecule. MAD phases were calculated to 2.5 A resolution and
improved by solvent ﬂipping, yielding an electron-density map of good
quality. On the basis of this map, an initial model was built with the
program Turbo-Frodo [24].
2.4. Reﬁnement of the structure as an ISG20–Mn2þ–UMP complex
To reﬁne the crystal structure as a complex with Mn2þ ions and
uridine 50-monophosphate (UMP), the data were collected at a
wavelength of 1.0 A, with a crystal which had been soaked for 2.5 h in
crystallization solution supplemented with 10 mM MnCl2 and 10 mM
UMP (Table 2). Five percent of the data was set aside for the calcu-
lation of Rfree and the remainder used to reﬁne the initial model at a
resolution of 1.9 A with the programs CNX and Turbo-Frodo. An
initial round of rigid-body reﬁnement was followed by repeated cycles
of simulated annealing, B-factor reﬁnement and model rebuilding, with
the last cycle including water-picking. The ﬁnal model contains resi-
dues 6–122 and 128–178 out of a total of 181 residues in the original
human protein and has two Mn2þ ions and one UMP molecule at its
active site (Fig. 1). Residues 123–127 were disordered and were
therefore excluded from the model. Suﬃcient electron density was also
not observed for the side chains of Glu6, Glu22, Gln62 and Arg171, so
these residues were built as Ala residues. Ramachandran plots were
analyzed by the program PROCHECK [25]. The reﬁnement statistics
are summarized in Table 3.
2.5. Identiﬁcation of manganese ions
To locate the Mn2þ ions in the crystal structure of the ISG20–Mn2þ–
UMP complex, the data were collected at a wavelength of 1.7 A, near
the K-absorption edge of Mn [26], from an ISG20–Mn2þ–UMP
complex crystal prepared as described above. The anomalous diﬀer-
ence Fourier map showed two large peaks in the region corresponding
to the active site (Fig. 1). In order to identify Mn2þ ions unambigu-
ously, data collection at wavelengths on both sides of the K-absorption
edge of Mn is usually necessary. However, the heights of these two
peaks were much greater than those of the peaks of the sulfur atoms of
the Met and Cys residues, and therefore two Mn2þ ions can reasonably
be assigned to these positions [27]. In addition to these two Mn2þ ions,
another Mn2þ ion associated with a slightly smaller, diﬀuse peak wasNative (complex) Native (complex)
(identiﬁcation of Mn2þ)
Remote
0.92 1.0 1.7
63.1, 97.8 63.42, 97.91 63.3, 97.8
50–2.5 (2.59–2.5) 50–1.9 (1.97–1.9) 50–2.5 (2.59–2.5)
28 163 65 192 25 869
8197 18 442 7900
99.9 (100) 99.6 (100) 95.7 (94.1)
13.6 (8.5) 23.9 (9.8) 19.1 (7.5)
6.1 (12.2) 3.9 (17.4) 5.3 (19.6)
–/1.89
0.60
average intensity of symmetry-related reﬂections.
Fig. 1. A simulated annealing Fo  Fc omit electron-density map of the
region of the active site contoured at 2 r (blue), generated by omitting
UMP and the two Mn2þ ions from the phase calculation. Superim-
posed on this is an anomalous diﬀerence Fourier electron density map
of the same region contoured at 10 r (orange), calculated from the data
collected at a wavelength of 1.7 A. UMP in the ﬁnal model is shown in
stick representation and the two Mn2þ ions as small spheres. Figs. 1–5
were generated with the PyMOLMolecular Graphics System (DeLano
Scientiﬁc, San Carlos, CA, USA; http://www.pymol.org) and the ray-
tracing renderer POV-ray (http://www.povray.org).
Table 3
Reﬁnement statistics
Resolution range (A) 20–1.9
No. of reﬂections, working set/test set 17 487/937
Rwork=Rfree 0.207/0.227
No. of reﬁned atoms
Protein atoms 1313
Solvent atoms 83
Mn and UMP atoms 24
Average B-factor (A2) 21.2
Rms deviations from ideality
Bond lengths (A) 0.006
Bond angles () 1.2
Dihedral angles () 22.6
Improper angles () 0.73
Ramachandran plot (%)
Most favored region 91.2
Additional allowed region 8.8
T. Horio et al. / FEBS Letters 577 (2004) 111–116 113found between the side chains of Asp90 and His93 (not shown). Al-
though this Mn2þ ion was probably not speciﬁcally bound to these side
chains, it was included in the reﬁnement. The atomic coordinates of the
structure have been deposited in the Protein Data Bank (PDB) with the
accession code 1WLJ.3. Results and discussion
3.1. Overall structure
The crystal structure of the ISG20–Mn2þ–UMP complex
determined by the MAD method at 1.9 A resolution (Fig. 2A)
can be seen to consist of a core ﬁve-stranded b-sheet with one
antiparallel strand (b2) and seven a-helices, with groups of two
(a3, a4) and ﬁve (a1, a2, a5–a7) helices on opposite sides of the
surface of the sheet. The whole molecule has a somewhat
elongated, ﬂat shape with approximate dimensions of
50 32 21 A3. The active site is located in the hollow nearFig. 2. Ribbon diagrams based on the crystal structures of (A) human ISG20,
(e186; PDB code 1J54 [12]), and (C) the N-terminal exonuclease domain of E.
ions bound at the active sites are shown in stick and sphere representations, re
site of ExoI.center of the molecule surrounded by b1, a1, a4, and the N-
terminal region of a7. When this structure is compared with
the crystal structures of two DNases in the DEDDh group, the
catalytic N-terminal domain of the e subunit of E. coli DNA
polymerase III (called e186; Fig. 2B) [12] and the E. coli exo-
nuclease I (abbreviated ExoI) exonuclease domain (Fig. 2C)
[13], the spatial arrangement of their secondary-structure ele-
ments can be seen to be very similar in spite of the low se-
quence identity (15%) and similarity (35%) between ISG20
and these DNase domains. Of the 168 Ca atoms in our ISG20
model, 138 can be superimposed on the corresponding Ca
atoms of e186 with a root-mean-square deviation (r.m.s.d.) of
2.15 A, while 132 can be superimposed on the corresponding
Ca atoms of ExoI with a r.m.s.d. of 2.25 A (Fig. 3).
However, there are several diﬀerences between ISG20 and
the two DNases (Fig. 2). First, the loop segment connecting b4
and b5 in ISG20 is rather short, so that, compared to the two
DNases, ISG20 has a short a4 helix and lacks the 310 helix that
the DNases have in this segment. Second, b1–b3 in ISG20
form a longer and more twisted b-sheet than they do in the two
DNases, and this also generates diﬀerences in the structures of
the loop segments connecting these b-strands. In addition, the(B) the N-terminal domain of the E. coliDNA polymerase III e subunit
coli ExoI (PDB code 1FXX [13]). In (A) and (B), nucleotides and Mn2þ
spectively. The sphere in (C) represents a Mg2þ ion found in the active
Fig. 3. Superposition of the Ca traces of (A) ISG20 (black) and e186
(pink), and (B) ISG20 (black) and the exonuclease domain of ExoI
(blue).
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the a5 helix of the two DNases.
3.2. Structure of the active site
Previous structural studies on the Klenow fragment of E.
coli DNA polymerase I, whose proofreading domain belongs
to DEDDy-group DNases, have shown that dTMP, a product
of the exonuclease reaction, binds at nearly the same position
as the 30-terminal nucleotide of the DNA substrate [14–16];
and this compound has also been used for the structural study
of e186 [12]. We used UMP instead of dTMP, because ISG20
is known to show a marked preference for RNA substrates. In
addition to UMP, manganese ions, which are essential for the
catalytic activity of ISG20 [8], were added to the soaking so-
lution to prepare an ISG20–Mn2þ–UMP-complex crystal.
According to the structure we have determined for the ISG20–
Mn2þ–UMP complex, the two Mn2þ ions, Mn A and Mn B, lie
about 3.8 A apart in the active site (Fig. 4A). DEDDh exon-
ucleases have ﬁve invariant residues that are crucial for the
structure of the active site [9]. Corresponding to these residues
in ISG20 are Asp11, Glu13, Asp94, His149 and Asp154. Our
model shows that the ligands to Mn A are carboxylate oxygens
of Asp11, Glu13 and Asp154 and oxygens O2P and O3P of the
UMP phosphate group. The ligands to Mn B are the otherFig. 4. Active-site structures of (A) ISG20 and (B) e186. Small blue spheres
ligands are shown as yellow dotted lines and hydrogen bonds as red dottedcarboxylate oxygens of Asp11, O3P of the UMP phosphate
group, and four water oxygens, with these ligands having an
octahedral coordination geometry. Of the four water mole-
cules coordinated to Mn B, two are held by hydrogen bonds
with carboxylate oxygens of Asp94. Comparison of this active
site structure with that of e186 clearly shows that the ar-
rangement of the ﬁve invariant residues is very similar (Fig. 4),
and comparison with ExoI (not shown) also reveals a similar
arrangement of these invariant residues. The crystal structure
of e186 has been solved at two diﬀerent pH values, 5.8 and 8.5
[12] (Table 1), and the structure shown in Fig. 4B is the one
solved at pH 5.8. The structures of e186 at the two diﬀerent pH
values are nearly identical, but there is a small diﬀerence in the
mode of binding of the phosphate group of dTMP at the active
site [12,17]. In our ISG20 model, the manner in which UMP
interacts with Mn2þ ions and the ﬁve invariant residues at pH
5.5 is almost identical to the manner in which dTMP interacts
with e186 at pH 5.8. The high similarity of the active-site
structures of ISG20 and e186 strongly suggests that the ﬁve
invariant residues in these enzymes fulﬁll the same catalytic
roles in the respective exonuclease reactions, and therefore that
the catalytic mechanisms are probably identical.
It is worth noting that His149 Nd of ISG20 forms a hy-
drogen bond with O2P of the UMP phosphate group. The
equivalent hydrogen bond is also observed in e186 at pH 5.8,
and it is considered to be one piece of evidence for the im-
portance of this histidine residue in the catalytic mechanism
[12]. According to the mechanism proposed for e186, a water
molecule (or hydroxide ion) is activated by His162 Nd and Mn
A, and carries out a nucleophilic attack on the phosphorus
atom of the 30-terminal phosphodiester group; the water
molecule thereby contributes a 50-monophosphate oxygen to
the mononucleotide product, corresponding to O2P of dTMP
(Fig. 4B) [12,17]. This mechanism is the same for DNA and
RNA substrates, so that the residues involved in distinguishing
these substrates must be present in an area other than the
active center.
3.3. Interaction with the nucleotide sugar moiety
ISG20 and e186 interact with the sugar moiety of the nu-
cleotide product as well as with the phosphate moiety. In
ISG20, Glu13 Oe1 and the main-chain nitrogen of Met14 arerepresent water molecules. Coordinate bonds between Mn2þ ions and
lines.
Fig. 5. Interactions between (A) UMP ribose and ISG20 and (B) dTMP deoxyribose and e186. Hydrogen bonds are shown as red dotted lines.
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2.8 A, respectively), whereas the main-chain carbonyl oxygen
of Met14 and Ng1 of Arg53 are within hydrogen-bonding
distance of the ribose 20-OH (2.6 and 2.8 A, respectively)
(Fig. 5A). In e186, the deoxyribose 30-OH of dTMP is ob-
served to make three hydrogen bonds, one with Glu14 Oe1,
one with the main-chain nitrogen of Thr15, and one with
His66 Nd (Fig. 5B) [12]. Given that Glu13 and Met14 of
ISG20 correspond to Glu14 and Thr15 of e186, the two en-
zymes interact with the sugar 30-OH group in a parallel man-
ner, except for the extra hydrogen bond with His66 in e186.
The fact that ISG20 can form two extra hydrogen bonds with
the 30-terminal nucleotide of RNA substrates leads one to
expect that RNA would be accommodated more favorably
than DNA, consistent with the observation that ISG20 de-
grades RNA far more rapidly than DNA [8]. In e186, in
contrast, RNA substrates are not likely to be accommodated
stably in the crystal structure, because of the expected steric
repulsion between the ribose 20-OH and Thr15 Oc. Instead, the
side chain of His66, which has no counterpart in ISG20, re-
inforces the interaction of e186 with DNA substrates. On these
grounds, DNA would be expected to be a more suitable sub-
strate for e186, in accordance with the known activity of this
exonuclease.
The side chain of Arg53 intrudes into the active site and
makes a hydrogen bond with the ribose 20-OH. In e186 and
ExoI, the position equivalent to the side chain of Arg53 is
occupied by a part of the protruding loop segment between b1
and b2. However, in ISG20 the corresponding segment forms
an extended b-sheet and cannot protrude into that position.
An assessment of whether the equivalent Arg residue is present
in the other DEDD RNases based solely on sequence align-
ment is diﬃcult because of the low sequence identity between
ISG20 and the other DEDD RNases, but S. cerevisiae Rex4, a
DEDDh RNase with 40% sequence identity to ISG20 [28], is
predicted to have the equivalent Arg residue. Meanwhile, an
equivalent residue is not found in the active site in the crystal
structure of Pop2, a DEDD-superfamily-related RNase [11].
Met14 is another notable residue, and its side chain occupies
a position that allows a hydrogen bond between the ribose 20-
OH and the main-chain oxygen of this residue, in contrast to
the corresponding side chain of Thr15 in e186, which would
clash with the ribose 20-OH of RNA substrates. Met14 of
ISG20 and Thr15 of e186 are the residues immediately fol-
lowing the invariant Glu residue that is found in the active site.The position of this Glu residue in the active site is considered
to be highly conserved in the DEDD exonucleases, so the
residue that directly follows this Glu residue in the sequence is
also expected to occupy a conserved position. Inspection of the
sequence of DEDD exonucleases shows that DNases tend to
have a Thr residue just after the invariant Glu residue, whereas
RNases tend to have a residue other than Thr. The only ap-
parent exception is the members of the RNase T subfamily,
which do have a Thr residue at this position. However, it is
reported that RNase T actually has higher activity towards
DNA substrates than RNA substrates [29]. All these facts
suggest that the presence of a Thr residue at this position in
DEDD exonucleases is unfavorable to the binding of RNA
substrates. Further study to investigate the putative role of
Arg53 and Met14 of ISG20 in the recognition of RNA sub-
strates would be of interest. In particular, mutating Arg53 to
another residue, and perhaps also mutating Met14 to a Thr
residue, may be expected to substantially reduce the activity of
ISG20 towards RNA substrates.
ISG20 has no residue to interact with the uracil part of
UMP, and residues that would be predicted to interact with
other bases are also not found. This result is consistent with
the fact that ISG20 is not a sequence-speciﬁc nuclease [8].
ISG20 is assumed to degrade viral or cellular RNA and to
contribute to the suppression of viral replication. The results of
our structural study suggest a rational explanation for ISG20’s
intrinsic preference for RNA substrates and its sequence-in-
dependent activity, properties expected to be critical for its
physiological role as an antiviral protein.
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